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ABSTRACT: The objective of this study was to devel-
op a validated, transient, chemically induced lameness 
model in sows using subjective and objective lameness 
detection tools. Experiment 1 determined an effective 
joint injection technique based on volume and place-
ment of dye using feet collected from 9 fi nisher pigs 
and 10 multiparity cull sow carcasses. Experiment 2 
confi rmed the injection technique in live animals and 
produced a transient clinical lameness in 4 anesthetized 
sows injected with amphotericin B (15 mg/mL) in the 
distal interphalangeal joints of the claw. Clinical lame-
ness was assessed by a categorical lameness scoring 
system, and a postmortem visual confi rmation of joint 
injection technique was obtained. In Exp. 3, 6 sows 
were injected with 0, 10, or 15 mg/mL amphotericin B 
in either the left or right hind foot and were monitored 
until clinical resolution. Treated sows demonstrated ele-
vated clinical lameness scores. These changes resolved 
by 7 d after lameness induction. Control sows injected 
with sterile saline developed a clinical lameness score 
of 0.5, which resolved 72 h post injection. In Exp. 4, 36 
sows were injected with 10 mg/mL amphotericin B in 
1 of 4 injection sites (left front claws, right front claws, 
left rear claws, and right rear claws). All injected sows 
exhibited a decrease in maximum pressure, stance time, 
and number of sensors activated on the GaitFour (P < 
0.05) sensor system. A static force plate also demon-
strated a decrease in weight (kg) being placed on the 
injected foot when all feet were injected (P ≤ 0.05). 
Injection of amphotericin B induced a predictable acute 
lameness that resolved spontaneously and is an effec-
tive method to model lameness in sows.
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INTRODUCTION
Lameness associated with painful joint lesions 
has been identifi ed as a welfare challenge for confi ned 
sows (Elmore et al., 2010). Lameness or feet and leg 
problems was ranked as the third greatest reason for 
culling sows, comprising 15% of the culls marketed 
in the United States (Schenk et al., 2010). Feet and leg 
problems were identifi ed as the most common invol-
untary reason for culling sows (Stalder et al., 2004) 
and also have been associated with several variables 
that result in poor reproductive performance, including 
decreased litter size, poor farrowing performance, and 
decreased sow longevity (Engblom et al., 2008; Anil 
et al., 2009).
There are no analgesic drugs approved for use 
in swine by the U.S. Food and Drug Administration 
(FDA). This is due to the lack of objective assess-
ment tools for pain, which are a requirement accord-
ing to FDA Guidance Document 123 (USDA, 2008). 
Developing objective assessment tools requires popula-
tions of known status, specifi cally painful and nonpain-
ful. Lameness is an externally observable manifestation 
of joint pain. Three successful lameness induction mod-
els using amphotericin B have demonstrated a predict-
able, acute synovitis in cattle (Kotschwar et al., 2009; 
Schulz et al., 2011) and horses (Bowman et al., 1983), 
with no long-term residual effects observed. Neither a 
procedure to inject the distal interphalangeal joints nor 
1This research was funded by the National Pork Board (09-073). 
The contributions of Allison Meiszberg and Lori Layman for animal 
management and data collection are acknowledged and greatly ap-
preciated.
2Corresponding author: johnsona@iastate.edu
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the effects of intra-articular amphotericin B in swine have 
been described in the scientifi c literature. Therefore, the 
objective of this study was to develop a validated, tran-
sient, chemically induced lameness model in sows using 
subjective and objective lameness detection tools.
MATERIALS AND METHODS
Sows were housed and fed individually accord-
ing to the Swine Care and Use Guidelines (Federation 
of Animal Science Society, 1999), and protocols were 
reviewed and approved by the Iowa State University 
Animal Care and Use Committee before conducting ex-
perimental work. Humane end point criteria were estab-
lished because at the onset of the experiment, lameness 
severity and duration resulting from injecting ampho-
tericin B into the distal interphalangeal joints in swine 
were unknown. The investigators established humane 
end point criteria so that any sow that progressed to non-
weight-bearing lameness for 48 h or was unable to ac-
cess water for >12 h or feed for >24 h was removed from 
the study and humanely euthanized.
Amphotericin B (X-Gen Pharmaceuticals, Inc., Big 
Flats, NY) was obtained as a sterile, nonpyrogenic, lyoph-
ilized powder containing 50 mg of amphotericin B and 
41 mg of sodium desoxycholate with 20.2 mg of sodium 
phosphate as buffer. The powder was reconstituted using 
sterile water to a concentration of 15 or 10 mg/mL as pre-
scribed by the respective experiment. When concentrated 
to 15 mg/mL, the resulting solution was cloudy and re-
quired almost constant agitation to maintain the solution. 
The 10 mg/mL concentration was dark yellow, but not 
cloudy, and did not require constant agitation for the am-
photericin B to remain suspended in the saline. Because 
of these observed differences in the chemicophysical 
properties, the goal of model development was to use the 
less concentrated of the 2 that created lameness.
Experiment 1: Determining 
Appropriate Injection Technique
Ten feet were disarticulated at the metacarpophalan-
geal joint from multiparity commercial sow carcasses 
obtained at harvest, and 9 feet from the carcasses of 
21-wk-old fi nishing pigs were obtained from a local har-
vest plant postmortem. Claws were placed in extension, 
and the distal interphalangeal joint was identifi ed by pal-
pation (both medial and lateral claws). The needle was 
inserted on the dorsal surface at the midline of the claw. 
Needle placement was confi rmed by joint fl uid aspira-
tion combined with injection of a FDA-approved meat 
marking dye (Hantover, Inc., Kansas City, MO; catalog 
number 40328). Beginning with a 20-gauge (ga) needle 
and 2 mL of fl uid volume, subsequently smaller needles 
and fl uid volumes were used. This methodology was 
continued until no leaking was observed from the injec-
tion site. It was determined that a 23-ga needle and 1-mL 
injection volume accomplished repeatable injection re-
sults. Smaller needle sizes and injection volumes were 
considered but arbitrarily rejected as impractical be-
cause of amphotericin B viscosity and formulation. The 
injection position was recorded using digital photogra-
phy. All feet were frozen at −20°C for 24 h, and each 
claw was sagittally sectioned. Sections were digitally 
photographed to confi rm the location of the injected dye 
in the distal interphalangeal joints.
Experiment 2: Intra-articular 
Injection in Live Animals
Four multiparity commercial cull sows with no ob-
servable clinical lameness signs were used in this trial. 
Clinical experience by the investigators suggested that 
injection at the distal interphalangeal joint in nonanes-
thetized sows was impractical, and anesthesia was 
indicated to ensure model repeatability. After being 
restrained by a humane hog snare, sows were anesthe-
tized by administering the following combination intra-
muscularly: xylazine (4.4 mg/kg BW; Anased, Lloyd 
Laboratories, Shenandoah, IA), Ketamine HCl (2.2 mg/
kg BW; Ketaset, Wyeth, Madison, NJ), and tiletamine 
HCl and zolazepam HCl (4.4 mg/kg BW) used in com-
bination (Telazol; Wyeth). During anesthesia, the entire 
claw was washed with mild soap and water to remove 
obvious organic material and fecal contamination. After 
this wash, the treated foot was scrubbed for 5 min with 
10% iodine-based surgical solution (Operand, Aplicare 
Inc., Branford, CT) using 10 × 10 cm sterile gauze pads. 
The foot was then rinsed with 70% isopropyl alcohol un-
til surgical scrub was removed. Approximately 10 min 
after anesthesia onset, sows were positioned in lateral 
recumbency, and injection sites were scrubbed a second 
time using the previously described procedures. After 
the second scrub, 0.8 mL of a 15 mg/mL amphotericin 
B (X-Gen Pharmaceuticals, Inc.) solution and 0.2 mL 
of meat marking dye (Hantover, Inc., catalog number 
40328) solution were mixed and injected in the intra-
articular space of the left rear, medial, distal interpha-
langeal joint.
Throughout anesthesia, heart rate (physical detection 
with the hand placed at third to fourth rib), respiratory 
rate (chest elevations resulting from inspiratory effort 
for 15 s), and rectal temperature were monitored every 
15 min until sows returned to a sternal position unaided. 
At 24 h after lameness induction, lameness was sub-
jectively confi rmed using a 5-point scale adapted from 
Crawford et al. (1991; Table 1). Once a sow exhibited a 
subjective lameness score ≥ 2, sows were humanely eu-
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thanized with a captive bolt gun (Accles and Shelvoke 
Ltd., West Midlands, UK). The injected foot was excised 
at the level of the hock and frozen for further sectioning 
and evaluation as previously outlined in Exp. 1.
Experiment 3: Response to 
Amphotericin B Injection in Live Sows
Six multiparity, clinically sound commercial sows 
were used. Sows were randomly allotted to 1 of 3 treat-
ments at the initiation of anesthesia. Two sows received 1 
mL of sterile saline control (CO), 2 sows received 1 mL 
of a 10 mg/mL amphotericin B concentrated solution 
(LO), and 2 sows received 1 mL of a 15 mg/mL solu-
tion (HI) injected in the intra-articular space of the left or 
right rear, medial, distal interphalangeal joint as outlined 
in Exp. 1. All joint injections occurred as sows were 
under general anesthesia by an intramuscular injection 
of half of the anesthetic dose used in Exp. 2 [xylazine 
(2.2 mg/kg BW; Anased, Lloyd Laboratories), ketamine 
HCl (1.1 mg/kg BW; Ketaset, Wyeth) and tiletamine HCl 
and zolazepam HCl (2.2 mg/kg BW) used in combination 
(Telazol, Wyeth)] to reduce recovery time. Preparation of 
the injection site and postinduction sow monitoring fol-
lowed the same protocols as used in Exp. 2.
Lameness Scoring
Immediately before anesthesia, sow lameness was 
assessed individually by 2 observers blinded to the 
treatment as sows were walking and standing, using 
the 5-point scale (Table 1). Individual sow lameness as-
sessment evaluations continued daily until lameness re-
solved. Observers were trained with this scoring system 
by reviewing examples of each score with both visual 
and descriptive training material before assessing indi-
vidual sows. This scoring system was chosen because 
it was previously used in an amphotericin B–induced 
model of lameness in ponies that monitored for resolu-
tion of the effect (Crawford et al., 1991).
Experiment 4: Characterization of Lameness Model
In group 1 a total of 24 multiparity commercial sows 
(parities 1 to 4) with no observable clinical signs of lame-
ness were used. Sows were randomly injected with 10 mg 
of amphotericin B in the distal interphalangeal joint of both 
claws in 1 of 4 injection sites: left front foot (LF), right 
front foot (RF), left rear foot (LR), and right rear foot (RR). 
In group 2 a total of 12 sows with no observable clinical 
signs of lameness were injected in the LR or RR sites only. 
All injections occurred using the anesthetic protocol as de-
scribed in Exp. 3. Sows were assessed for lameness using 2 
objective measurement tools: GaitFour (CIR Systems, Inc., 
Havertown, PA) and an Embedded Microcomputer Force 
Plate System (static force plate; see Sun et al., 2011). This 
process was repeated after a 13-d washout period on the re-
maining uninjected feet for group 1 sows and the alternate 
rear foot for group 2 sows. All sows appeared clinically 
sound and showed no signs of lameness from previous in-
jection on day of second injection.
GaitFour Walkway System. To assess sow movement, 
a GaitFour pressure mat was used to measure maximum 
pressure (kg/cm2), stride length (cm), stance time (s), ac-
tivated sensor count, and stride time (s) per foot during 
walking. The pressure mat was installed on a level fl oor 
surface in the facility where experiments occurred. The 
electronic walkway was created by connecting multiple 
sensors pads. Each sensor pad was 61 cm2 and contained 
2,304 sensors. The sensors were activated by pressure. 
Maximum pressure was defi ned as the greatest amount 
of weight placed on a single foot. Stride length was mea-
sured as the distance between 2 consecutive footfalls 
from the same foot. Stance time was the duration of time 
the sensors were activated (pressure was applied to the 
mat) by a foot in a single stride. Stride time was defi ned as 
the time between 2 consecutive footfalls by the same foot.
The walkway system was connected to a laptop 
computer, and 2 digital video cameras (Victor Company 
of Japan, Yokohama, Japan) were placed on each end of 
the walkway to record sows as they walked across the 
walkway. GaitFour software was synchronized with a 
video recording the walk of each sow. Each sow walked 
across the pressure mat until 3 passes occurred without 
the sow stopping or running on the mat surface. The 3 
walking passes per sow were recorded, and each pass 
Table 1. Categorical 5-point scoring system used for subjective evaluation in studying induced lameness in sows1
Lameness score Description
0 Sow moves freely and uses all 4 limbs and feet evenly
1 Sow shows weight-shifting activities away from affected limb upon standing but shows little or no lameness or limping when walking
2 Sow obviously shifts weight away from affected limb when standing and shows 
limping or adaptive behavior when walking (head bob, quickened step on affected limb)
3 Sow is reluctant to stand and/or walk, obvious limp and adaptive behaviors when walking
4 Sow is nonweight bearing on the affected limb when either standing or walking
1Adapted from Crawford et al. (1991).
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included at least 2 strides. Footfalls were individually 
highlighted (identifi ed using video if necessary), sorted 
by initial footfall time on the pressure mat, and saved as 
a completed walk with a unique fi le name. Data from 
completed walks were compiled by exporting into a 
spreadsheet for further analysis. Data were collected 
on D-1 (day before joint injection), D+1 (fi rst day after 
joint injection), and D+5 (fi fth day postinjection) for all 
36 sows. For the subset of 12 sows, data were also col-
lected on D+7 (seventh day postinjection)
Embedded Microcomputer Force Plate System. 
The Embedded Microcomputer Force Plate System (stat-
ic force plate) was developed at Iowa State University 
to objectively identify sows that possess varying lame-
ness severities (Sun et al., 2011). The static force plate 
was designed with a total dimension of 1,524 × 565 × 
106 mm (length × width × height), with 6.4-mm-thick 
aluminum plating composing the top and bottom plates. 
A semifl exible epoxy (FlexCoat Vanberg Specialized 
Coatings, Lenexa, KS) was mixed with sand to mimic 
the fl oor type that a sow would stand on daily. Sows were 
walked into a standard gestation stall with the fl ooring 
replaced by the static force plate. Sows remained in the 
stall for 15 min. This plate measured each foot indepen-
dently and was able to detect weight shifting activities 
as the sow was standing. Data were collected on D-1, 
D+1, and D+5 for all 36 sows. For the subset of 12 sows, 
data were also collected on D+7.
Statistical Analysis
Descriptive statistics were calculated from Exp. 1, 2, 
and 3 data. Statistical analysis of the differences between 
sound feet and the injected foot for GaitFour and static 
force plate parameters from Exp. 4 was conducted using 
SAS software (SAS Inst. Inc., Cary, NC). Footfall pa-
rameter measurements from the GaitFour were analyzed 
statistically as 3 paired ratios to evaluate sow locomotor 
compensation and lameness correction. The 3 ratios eval-
uated were lateral foot (i.e., if LR foot was injected, it was 
paired as a ratio to RR foot), same side (i.e., if LR foot 
was injected, it was paired as a ratio to the LF foot), and 
contralateral (i.e., if LR foot was injected, it was paired 
as a ratio to the RF foot). The ratios for total activated 
sensors, maximum pressure, stride length, stride time, 
and stance time were analyzed using the ProcMixed pro-
cedure from SAS. Days post lameness induction (DPI), 
treatment level (trt), and the interaction of DPI × trt were 
included as fi xed effects, with sow as a random effect in 
the models used to analyze these data. Weight distribution 
on the static force plate for each individual foot (LF, RF, 
LR, and RR) was compared with the other noninjected 
feet and was analyzed using MIXED model procedures 
from SAS. Day of collection, day after lameness induc-
tion, treatment, and foot were included as fi xed effects 
in the model, and sow within treatment by day of collec-
tion was included as a random effect. The injection num-
ber did not explain a signifi cant amount of variation and 
so was removed from the model for both the static force 
plate and GaitFour analyses.
RESULTS
Experiment 1: Determining 
Appropriate Injection Technique
Within the range of needle gauges and fl uid vol-
umes tested, it was not possible to inject feet collected 
from 21-wk old fi nisher pigs without obvious back fl ow 
through the injection site and inconsistent fl uid deposi-
tion into the distal interphalangeal joint space. Using 
feet collected from multiparity commercial cull sow car-
casses, 22-mm, 23-ga needles with 1 mL of fl uid vol-
ume resulted in accurate injection without dye fl ow back 
through the injection track. All frozen sagittal sections 
confi rmed dye placement in the distal interphalangeal 
joint (Fig. 1).
Experiment 2: Intra-articular Injection in Live Animals
At the start of the experiment all sows received lame-
ness score 0 and were determined to be clinically sound. 
The observed effects of anesthesia used on all sows per-
sisted for <12 h. At 24 h postinjection, all sows received a 
lameness score of 2. Each sow was humanely euthanized 
once a lameness score of 2 was achieved, and postmortem 
sectioning of injected feet demonstrated dye in the distal 
interphalangeal joint in all cases (data not presented).
Figure 1. Evidence of correct injection placement in the distal inter-
phalangeal joint of sow feet using a 23-guage needle and meat branding dye.
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Experiment 3: Response to 
Amphotericin B Injection in Live Sows
At the start of the experiment all sows received lame-
ness score 0 and were determined to be clinically sound. 
The anesthesia duration was shorter at the smaller anes-
thetic dose, with all sows recovering within 8 h. All injec-
tions (CO, LO, and HI) were administered successfully. 
The CO sow group achieved a maximum average lame-
ness score of 0.5 at 24 h, which returned to 0 at 72 h after 
lameness induction. Lameness scores for LO and HI sows 
were numerically greater compared with CO sows for 
every time point until returning to baseline. The HI sow 
group returned to baseline 48 h earlier than the LO group; 
however, scores at 24 and 48 h after lameness induction 
were greater for HI sows than LO sows (Fig. 2).
Experiment 4: Characterization of Lameness Model
GaitFour Analysis. For the 24 sows (group 1) that 
were allotted randomly to have any 1 of 4 feet injected, 
there was a decrease (P ≤ 0.05) in maximum pressure, 
stance time, and number of sensors activated for all ratios 
when comparing the sow before (D-1) and after (D+1) 
injection (Table 2). Results from the additional 12 sows 
(group 2) where only rear feet were injected were con-
sistent with group 1. There was a decrease (P ≤ 0.05) in 
stance time for all 3 paired ratios when comparing data 
collected on D-1 and D+1. There was a decrease (P ≤ 
0.05) in maximum pressure from the lateral side and con-
tralateral foot paired ratios and a decrease (P ≤ 0.05) in 
number of sensors for the contralateral side and same side 
paired ratios.
Static Force Plate Analysis. Table 3 shows the static 
force plate analysis results for groups 1 and 2, respective-
Figure 2. Average lameness scores by hours postinjection and dose in 
sows injected in the distal interphalangeal joint with amphotericin B in Exp. 
3. Sows were subjectively evaluated for evidence of lameness using a 5-point 
scale adapted from Crawford et al. (1991).Control sows were injected with 
1 mL of sterile saline control (diamonds); low sows were injected with 1 mL 
of 10 mg/mL amphotericin B (squares), and high sows were injected with 1 
mL of 15 mg/mL amphotericin B (triangles). Time is defi ned as time after 
lameness induction.
Table 2. Means for the lateral side, same side, and contra-
lateral ratios for footfall parameters adjusted for the effect 
of the sow and treatment on the day before joint injection 
(D-1) and the fi rst day after joint injection (D+1) using the 
GaitFour system from sows injected with amphotericin B 
to induce lameness1
Ratio Parameters2 D-1 D+1
Group 1 (24 sows)
Lateral side Maximum pressure 0.980 ± 0.030a 0.781 ± 0.030b
Stride length 0.997 ± 0.002 0.992 ± 0.002
Stance time 1.006 ± 0.026a 0.823 ± 0.026b
Number of sensors 0.985 ± 0.027a 0.827 ± 0.027b
Stride time 1.001 ± 0.023 1.003 ± 0.024
Same side Maximum pressure 1.021 ± 0.025a 0.902 ± 0.025b
Stride length 1.001 ± 0.002 1.002 ± 0.002
Stance time 1.015 ± 0.027a 0.914 ± 0.027b
Number of sensors 1.002 ± 0.021a 0.945 ± 0.021b
Stride time 0.997 ± 0.020 0.999 ± 0.020
Contralateral Maximum pressure 1.012 ± 0.019a 0.856 ± 0.019b
Stride length 0.998 ± 0.003 0.993 ± 0.003
Stance time 1.015 ± 0.024a 0.891 ± 0.025b
Number of sensors 0.997 ± 0.017a 0.908 ± 0.017b
Stride time 0.999 ± 0.021 1.002 ± 0.021
Group 2 (12 sows)
Lateral side Maximum pressure 0.950 ± 0.026a 0.688 ± 0.025b
Stride length 1.000 ± 0.003 1.000 ± 0.003
Stance time 1.007 ± 0.015a 0.797 ± 0.015b
Number of sensors 0.959 ± 0.051 0.837 ± 0.049
Stride time 0.990 ± 0.010 1.010 ± 0.010
Same side Maximum pressure 0.707 ± 0.019a 0.520 ± 0.019b
Stride length 0.995 ± 0.002 1.000 ± 0.002
Stance time 0.933 ± 0.016a 0.888 ± 0.016b
Number of sensors 0.772 ± 0.019a 0.620 ± 0.019b
Stride time 0.987 ± 0.010 1.008 ± 0.010
Contralateral Maximum pressure 0.701 ± 0.033a 0.521 ± 0.032b
Stride length 0.999 ± 0.003 1.000 ± 0.003
Stance time 0.947 ± 0.013a 0.826 ± 0.013b
Number of sensors 0.763 ± 0.016a 0.630 ± 0.015b
Stride time 1.000 ± 0.010 1.007 ± 0.010
a,bMeans within a row without a common superscript differ (P < 0.05).
1The lateral side ratio is defi ned as the value for the treated foot divided by 
the untreated foot lateral to the treated foot. For example, if the left front foot is 
treated, the right front foot is the untreated foot in the ratio. If the right front foot 
is treated, the left front foot is the untreated foot in the ratio. The same side ratio 
is defi ned as the value for the treated foot divided by the untreated foot anterior 
or posterior to the treated foot. For example, if the left front foot is treated, the 
left rear foot is the untreated foot in the ratio. If the right rear foot is treated, 
the right front foot is the untreated foot in the ratio. The contralateral ratio is 
defi ned as the value for the treated foot divided by the untreated foot anterior 
or posterior and lateral to the treated foot. For example, if the left front foot is 
treated, the right front foot is the untreated foot in the ratio. If the right front foot 
is treated, the left front foot is the untreated foot in the ratio. Sows were injected 
with 1 mL of 10 mg/mL amphotericin B.
2The GaitFour (CIR Systems, Inc., Havertown, PA) pressure mat measures 
footfall parameters using pressure-activated sensors. The maximum pressure 
is the largest amount of weight place on a single foot. Stride length is the 
distance between 2 consecutive footfalls from the same foot. Stance time is 
the time between 2 consecutive footfalls of the same foot when the sensors 
are activated (pressure is applied to the mat). Stride time is the time between 
2 consecutive footfalls of the same foot. The number of sensors is the count 
of the sensors activated by each foot.
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ly. For the group 1 sows, a difference (P < 0.05) between 
the weight being placed on the injected foot and the lateral 
foot on the day after lameness induction was observed re-
gardless of the leg that was injected. This difference was 
still present on D+5 for sows injected on the RF, LR, and 
RR. The difference in the LF was resolved by the last day 
of data collection (D+5; Table 3). For the group 2 sows, 
which only included rear feet evaluation, injection of both 
rear feet revealed a change (P < 0.05) in weight being 
placed on the injected foot compared with the lateral foot 
on the day after lameness induction (D+1) and D+5. By 
D+7 (last day of data collection), lameness had resolved 
so that no weight difference (P > 0.05) between injected 
and noninjected feet was detected.
DISCUSSION
These experiments established a protocol for induc-
ing a transient clinical lameness in sows by amphoteri-
cin B injection into the distal interphalangeal joint. This 
lameness in sows was distinguishable from their prein-
jection gait by the subjective lameness score, GaitFour, 
and static force plate assessment. Lameness was no lon-
ger detected by static force plate or by subjective lame-
ness scores by 7 d postinjection. The ability to induce 
lameness allows sows to be used as their own control and 
provides a population of known status to study lameness 
detection methods and devices. Data collection on the 
same sow when both sound and lame increase the study 
power by reducing within-animal variation and allow for 
a reduction in total sample size required for signifi cance.
Amphotericin B was injected using 10 and 15 mg/mL 
concentrations. The 2 concentrations included in Exp. 2 
were chosen arbitrarily because previous work suggesting 
an effective dose was lacking in the scientifi c literature. 
The results of these experiments suggest the 10 mg/mL 
concentration was suffi cient to induce a repeatable tran-
sient lameness in sows. The investigators regarded the 
lowest dose that induced repeatable lameness to be pref-
erable, and the 15 mg/mL concentration was not evalu-
ated further. A 10 mg/mL concentration may represent the 
maximum concentration for repeatability because the am-
photericin B tended to precipitate out of suspension at the 
15mg/mL concentration. Using this concentration would 
make it diffi cult to consistently deliver the same quantity 
of the active substance at each distal interphalangeal joint.
Experiment 4 revealed a decrease in sensor activa-
tion as well as weight shifting to the nonlame foot and 
demonstrated a decrease in maximum pressure and stance 
time on the injected foot. Because of the inability to iso-
late claws individually, the GaitFour may not be a suit-
able tool to distinguish asymmetrical claw effects on the 
same foot but does demonstrate accurate lameness detec-
tion when both claws are injected or when determining 
clinical lameness that involves the entire foot or leg in a 
fi eld setting that cannot be localized to a specifi c point. 
Experiment 4 showed that the GaitFour detected gait 
changes on all sows when lame was induced, and these 
gait changes resolved when the clinical lameness resolved.
The static force plate revealed a decrease in weight (kg) 
placed on the injected foot regardless of which foot was in-
jected. Previous work by Knauer et al. (2007) revealed hoof 
lesions as the most prevalent lesion present in Midwestern 
cull sows. In this study, the experimental design did not 
measure an association between hoof lesions and clinical 
lameness. A repeatable lameness model would be useful for 
validating objective devices for detection of lame animals, 
benefi ting farmers managing breeding herd sows.
Table 3. Mean weight (kg) measured on each foot with 
the static force plate when sows were injected with 




D-13 D+13 D+53 D+73
Group 1 (24 sows)
LF LF 57.44 ± 2.67 36.85 ± 3.19a 58.17 ± 2.39 −
RF 58.14 ± 2.67 68.86 ± 3.19b 62.16 ± 2.39 −
LR 41.24 ± 2.67 41.67 ± 3.19 43.29 ± 2.39 −
RR 43.50 ± 2.67 47.65 ± 3.19 45.40 ± 2.39 −
RF LF 57.02 ± 2.31 67.21 ± 3.58a 58.40 ± 2.03a −
RF 58.38 ± 2.31 43.52 ± 3.58b 54.91 ± 2.03b −
LR 41.39 ± 2.31 37.16 ± 3.58 40.29 ± 2.03 −
RR 44.72 ± 2.31 44.15 ± 3.58 42.78 ± 2.03 −
LR LF 54.30 ± 1.94 55.78 ± 2.28 54.36 ± 2.46 −
RF 57.59 ± 1.94 60.37 ± 2.28 58.84 ± 2.46 −
LR 42.10 ± 1.94 25.54 ± 2.28a 37.18 ± 2.46a −
RR 42.01 ± 1.94 50.18 ± 2.28b 44.55 ± 2.46b −
RR LF 52.83 ± 2.78 55.33 ± 3.16 53.41 ± 2.84 −
RF 57.19 ± 2.78 57.33 ± 3.16 56.69 ± 2.84 −
LR 40.88 ± 2.78 49.50 ± 3.16a 43.64 ± 2.84a −
RR 41.67 ± 2.78 22.85 ± 3.16b 35.43 ± 2.84b −
Group 2 (12 sows)
LR LF 54.38 ± 2.62 56.03 ± 2.62 57.24 ± 2.58 57.28 ± 2.63
RF 58.28 ± 4.88 62.70 ± 4.87 60.33 ± 4.86 61.63 ± 4.88
LR 39.60 ± 2.86 27.25 ± 2.85a 38.23 ± 2.82a 41.87 ± 2.88
RR 41.36 ± 2.72 48.89 ± 2.72b 43.93 ± 2.71b 42.41 ± 2.72
RR LF 58.54 ± 4.32 56.44 ± 4.31 55.78 ± 4.31 58.10 ± 4.35
RF 62.68 ± 4.07 64.13 ± 4.06 61.53 ± 4.06 62.10 ± 4.08
LR 45.96 ± 3.02 53.81 ± 3.02a 47.88 ± 3.01a 46.48 ± 3.06
RR 45.22 ± 3.26 24.93 ± 3.25b 38.56 ± 3.25b 43.61 ± 3.28
a,bMeans within a treated foot are compared with the lateral foot, and 
means without a common superscript differ (P < 0.05).
1The Embedded Microcomputer Force Plate System (static force plate) 
was developed at Iowa State University to objectively identify sows that pos-
sess varying lameness severities (Sun et al., 2011).
2LF = left front foot, RF = right front foot, LR = left rear foot, and RR = 
right rear foot.
3D-1 = clinically sound day, D+1 = day after injection, D+5 = 5 d after injec-
tion, and D+7 = 7 d after injection.
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Lame sows are often euthanized on farm, contribut-
ing to increased breeding herd mortality rates. Kirk et 
al. (2005) reported that over 70% of breeding herd sows 
with mobility problems are euthanized. Current lame-
ness evaluation methods are subjective and biased by the 
observer (Crawford et al., 1991; Zinpro, 2011). To assist 
swine producers and veterinarians with lameness preven-
tion and treatment, validated objective tools to detect sow 
lameness are needed. A consistent sow lameness model 
was developed in this series of studies, and new objective 
lameness tools were used and signifi cant differences were 
observed. The ability to evaluate the same individual ani-
mal, both as sound and lame, controls for a wide range of 
specifi c gait variations, conformational differences, infl u-
ence of BW, and hoof structure variables. The transient 
lameness duration is particularly important if the model 
is to have value for future pharmacologic assessment of 
analgesic molecules (USDA, 2008). Breeding herd lame-
ness is a signifi cant animal welfare and economical is-
sue in the United States and worldwide. The induced sow 
lameness model outlined in the present studies is useful 
to gain a better understanding of clinical breeding herd 
lameness. The sow lameness model and objective tools 
can be applied to future pharmacological pain mitigation 
studies. In addition, future work could involve validating 
the objective lameness detection tools in the fi eld.
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